TP53 and metastatic neoplasm: This hyperexpression was particularly prevalent in recurrent or metastatic tumors, suggesting that the presence of the wild-type p53 protein may correlate with more aggressive tumor behavior and an increased likelihood of recurrence, although the study found no direct evidence of p53 mutations driving tumor development [43].